Stock data
Takeda Pharmaceutical Company$27.00
4502 
0.21% • 24 H
0.21% • 24 HDividend Yield:4.2%
Global Rank#416
Market Cap$41.91B
YTD Performance3.09%
P/E0.13
Revenue$25.65B
Change 7d3.06%
SP500 BenchmarkUnderperform
Country🇯🇵 Japan
P/S1.63
Earnings$2.02B
Dividend Yield:4.2%
Main Sector
Healthcare
Takeda Pharmaceutical Company (4502) Cash on Hand
4502 Cash on Hand in 2022: $3.53B
According to Takeda Pharmaceutical Company latest financial reports the cash on hand of 4502 is $3.53B, an decrease of -36.72% to 2022. At the end of 2022 company had $5.57B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
4502 Cash on Hand History from 2019 to 2023
-
Value:-
4502 Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $3.53B | -36.72% |
| 2022 | $5.57B | -12.75% |
| 2021 | $6.39B | 53.47% |
| 2020 | $4.16B | -9.92% |
| 2019 | $4.62B | - |
View the Top Cash on Hand Companies 
